EMEA-001078-PIP01-10
Key facts
| Active substance |
Lixivaptan
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/257/2011
|
| PIP number |
EMEA-001078-PIP01-10
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of hyponatraemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Cardiokine Biopharma, LLC
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|